<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Neuroone Medical Technologies Corp — News on 6ix</title>
<link>https://6ix.com/company/neuroone-medical-technologies-corp</link>
<description>Latest news and press releases for Neuroone Medical Technologies Corp on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 14 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/neuroone-medical-technologies-corp" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835a29178dffbe2df109c86.webp</url>
<title>Neuroone Medical Technologies Corp</title>
<link>https://6ix.com/company/neuroone-medical-technologies-corp</link>
</image>
<item>
<title>NeuroOne(R) Medical Technologies Announces Reverse Stock Split to Regain Nasdaq Compliance</title>
<link>https://6ix.com/company/neuroone-medical-technologies-corp/news/neurooner-medical-technologies-announces-reverse-stock-split-to-regain-nasdaq-compliance</link>
<guid isPermaLink="true">https://6ix.com/company/neuroone-medical-technologies-corp/news/neurooner-medical-technologies-announces-reverse-stock-split-to-regain-nasdaq-compliance</guid>
<pubDate>Tue, 14 Apr 2026 04:00:00 GMT</pubDate>
<description>EDEN PRAIRIE, MINN. - April 14, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC), a medical technology company dedicated to</description>
</item>
<item>
<title>NeuroOne(R) Medical Technologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)</title>
<link>https://6ix.com/company/neuroone-medical-technologies-corp/news/neurooner-medical-technologies-reports-inducement-grant-under-nasdaq-listing-rule-5635c4</link>
<guid isPermaLink="true">https://6ix.com/company/neuroone-medical-technologies-corp/news/neurooner-medical-technologies-reports-inducement-grant-under-nasdaq-listing-rule-5635c4</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>EDEN PRAIRIE, MINN. - April 2, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC), a medical technology company dedicated to</description>
</item>
<item>
<title>NeuroOne(R) Successfully Completes Limited Market Release of OneRF(R) Trigeminal Nerve Ablation System</title>
<link>https://6ix.com/company/neuroone-medical-technologies-corp/news/neurooner-successfully-completes-limited-market-release-of-onerfr-trigeminal-nerve-ablation-system</link>
<guid isPermaLink="true">https://6ix.com/company/neuroone-medical-technologies-corp/news/neurooner-successfully-completes-limited-market-release-of-onerfr-trigeminal-nerve-ablation-system</guid>
<pubDate>Thu, 26 Mar 2026 04:00:00 GMT</pubDate>
<description>12 Patients Successfully Treated Across Three Leading Centers, With All Patients Reporting Freedom From Pain* Early Experience Highlights Improved Patient</description>
</item>
<item>
<title>NeuroOne(R) Announces Publication of Clinical Experience With Its OneRF(R) sEEG-Guided Radiofrequency Ablation Technology</title>
<link>https://6ix.com/company/neuroone-medical-technologies-corp/news/neurooner-announces-publication-of-clinical-experience-with-its-onerfr-seeg-guided-radiofrequency-ablation-technology</link>
<guid isPermaLink="true">https://6ix.com/company/neuroone-medical-technologies-corp/news/neurooner-announces-publication-of-clinical-experience-with-its-onerfr-seeg-guided-radiofrequency-ablation-technology</guid>
<pubDate>Tue, 17 Mar 2026 12:30:00 GMT</pubDate>
<description>Peer-Reviewed Case Series Supports Safe Integration into Existing Stereotactic Workflow, Bedside Treatment Capability, and Reductions in Seizure Burden in Patients with Drug-Resistant Epilepsy* EDEN PRAIRIE, MINN. - March 17, 2026 (NEWMEDIAWIRE) - Ne...</description>
</item>
<item>
<title>NeuroOne(R) to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference March 17, 2026 at 1:20 p.m. Eastern Time</title>
<link>https://6ix.com/company/neuroone-medical-technologies-corp/news/neurooner-to-present-at-the-oppenheimer-36th-annual-healthcare-medtech-and-services-conference-march-17-2026-at-120-pm-eastern-time-28</link>
<guid isPermaLink="true">https://6ix.com/company/neuroone-medical-technologies-corp/news/neurooner-to-present-at-the-oppenheimer-36th-annual-healthcare-medtech-and-services-conference-march-17-2026-at-120-pm-eastern-time-28</guid>
<pubDate>Wed, 11 Mar 2026 04:00:00 GMT</pubDate>
<description>EDEN PRAIRIE, MINN. - March 11, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical</description>
</item>
<item>
<title>NeuroOne(R) Issues Shareholder Letter and Provides Corporate Update</title>
<link>https://6ix.com/company/neuroone-medical-technologies-corp/news/neurooner-issues-shareholder-letter-and-provides-corporate-update</link>
<guid isPermaLink="true">https://6ix.com/company/neuroone-medical-technologies-corp/news/neurooner-issues-shareholder-letter-and-provides-corporate-update</guid>
<pubDate>Mon, 09 Mar 2026 04:00:00 GMT</pubDate>
<description>Commercial Momentum Accelerates with Record OneRF® Procedure Volume in Fiscal Q1 '26 and Early Trigeminal Success Platform Advancing Across Three New $1B+</description>
</item>
<item>
<title>NeuroOne(R) Appoints David Wambeke as Chief Business Officer; Concurrently Completes Insider Purchase of 1 Million Shares</title>
<link>https://6ix.com/company/neuroone-medical-technologies-corp/news/neurooner-appoints-david-wambeke-as-chief-business-officer-concurrently-completes-insider-purchase-of-1-million-shares</link>
<guid isPermaLink="true">https://6ix.com/company/neuroone-medical-technologies-corp/news/neurooner-appoints-david-wambeke-as-chief-business-officer-concurrently-completes-insider-purchase-of-1-million-shares</guid>
<pubDate>Tue, 03 Mar 2026 13:30:00 GMT</pubDate>
<description>Proven Healthcare Leader with Capital Markets Expertise to Support Strategic Expansion; Personal Investment Signals Strong Conviction in Company's Strategic Growth EDEN PRAIRIE, MINN. - March 3, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Cor...</description>
</item>
<item>
<title>NeuroOne(R) to Host Virtual Investor Webinar on Thursday, March 12, 2026 at 11:30 a.m. Eastern Time</title>
<link>https://6ix.com/company/neuroone-medical-technologies-corp/news/neurooner-to-host-virtual-investor-webinar-on-thursday-march-12-2026-at-1130-am-eastern-time</link>
<guid isPermaLink="true">https://6ix.com/company/neuroone-medical-technologies-corp/news/neurooner-to-host-virtual-investor-webinar-on-thursday-march-12-2026-at-1130-am-eastern-time</guid>
<pubDate>Thu, 26 Feb 2026 13:29:34 GMT</pubDate>
<description>EDEN PRAIRIE, MINN - February 26, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurologica...</description>
</item>
<item>
<title>NeuroOne Reports Fiscal Q1 2026 Financial Results; Expects Product Revenue of At Least $10.5 Million in Fiscal Year 2026</title>
<link>https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-reports-fiscal-q1-2026-123000500</link>
<guid isPermaLink="true">https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-reports-fiscal-q1-2026-123000500</guid>
<pubDate>Tue, 17 Feb 2026 12:30:00 GMT</pubDate>
<description>Nearly 50% of all Ablations Since OneRF(R) Ablation System Product Launch in 2024 were Performed in Fiscal Q1 2026, Showing Growing Adoption Following FDA 510(k) Clearance, Successfully Completed Nine Trigeminal Neuralgia Cases to Date, with All Pati...</description>
</item>
<item>
<title>NeuroOne(R) to Report First Quarter Fiscal Year 2026 Financial Results on Tuesday, February 17 at 8:30 a.m. Eastern Time</title>
<link>https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-r-report-first-quarter-210100609</link>
<guid isPermaLink="true">https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-r-report-first-quarter-210100609</guid>
<pubDate>Wed, 04 Feb 2026 21:01:00 GMT</pubDate>
<description>EDEN PRAIRIE, MINN. - February 4, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurologica...</description>
</item>
<item>
<title>NeuroOne(R) Appoints Jason Mills to the Board of Directors</title>
<link>https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-r-appoints-jason-mills-123000469</link>
<guid isPermaLink="true">https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-r-appoints-jason-mills-123000469</guid>
<pubDate>Mon, 22 Dec 2025 12:30:00 GMT</pubDate>
<description>Veteran Med-Tech Research Analyst & Public Company Executive to Bring Strategic Experience, Industry Relationships and Vision to the Board EDEN PRAIRIE, MINN. - December 22, 2025 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq:...</description>
</item>
<item>
<title>NeuroOne Reports Strong Fourth Quarter Fiscal 2025 Financial Results With Product Revenue Growth of 907% to $2.7 Million and 55.8% Gross Margin & Total Revenue Growth of 163% to $9.1 Million for Fiscal Year 2025</title>
<link>https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-reports-strong-fourth-quarter-123000588</link>
<guid isPermaLink="true">https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-reports-strong-fourth-quarter-123000588</guid>
<pubDate>Wed, 17 Dec 2025 12:30:00 GMT</pubDate>
<description>Revenue Growth Fueled by Sales of the OneRF(R) Ablation System FDA 510(k) Clearance for OneRF(R) Trigeminal Nerve Ablation System with First Two Facial Pain Patients Successfully Treated Strengthened Balance Sheet Funds Growth Through Fiscal Year 202...</description>
</item>
<item>
<title>NeuroOne(R) to Report Fourth Quarter and Fiscal Year 2025 Financial Results on Wednesday, December 17th at 8:30 a.m. Eastern Time</title>
<link>https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-r-report-fourth-quarter-210000797</link>
<guid isPermaLink="true">https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-r-report-fourth-quarter-210000797</guid>
<pubDate>Thu, 11 Dec 2025 21:00:00 GMT</pubDate>
<description>EDEN PRAIRIE, MINN. - December 11, 2025 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients sufferi...</description>
</item>
<item>
<title>NeuroOne(R) Announces Initial Successful Cases Completed With OneRF(R) Trigeminal Nerve Ablation System at the University Hospitals in Cleveland</title>
<link>https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-r-announces-initial-successful-133000095</link>
<guid isPermaLink="true">https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-r-announces-initial-successful-133000095</guid>
<pubDate>Tue, 09 Dec 2025 13:30:00 GMT</pubDate>
<description>Patients Reported Pain Relief Without Postoperative Complications Further Validates NeuroOne's Patented Platform Technology for Both Brain Ablation and Pain Management Procedures EDEN PRAIRIE, MINN. - December 9, 2025 (NEWMEDIAWIRE) - NeuroOne Medic...</description>
</item>
<item>
<title>NeuroOne(R) Announces Upcoming Industry Conference Participation</title>
<link>https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-r-announces-upcoming-industry-133000208</link>
<guid isPermaLink="true">https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-r-announces-upcoming-industry-133000208</guid>
<pubDate>Wed, 19 Nov 2025 13:30:00 GMT</pubDate>
<description>EDEN PRAIRIE, MINN. - November 19, 2025 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients sufferi...</description>
</item>
<item>
<title>NeuroOne(R) Receives 180-Day Extension From Nasdaq to Regain Minimum Bid Price Compliance</title>
<link>https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-r-receives-180-day-133000127</link>
<guid isPermaLink="true">https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-r-receives-180-day-133000127</guid>
<pubDate>Wed, 05 Nov 2025 13:30:00 GMT</pubDate>
<description>EDEN PRAIRIE, MINN. - November 5, 2025 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients sufferin...</description>
</item>
<item>
<title>NeuroOne Promotes Emily Johns to Chief Administrative Officer</title>
<link>https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-promotes-emily-johns-chief-133139513</link>
<guid isPermaLink="true">https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-promotes-emily-johns-chief-133139513</guid>
<pubDate>Thu, 16 Oct 2025 13:31:39 GMT</pubDate>
<description>EDEN PRAIRIE, MINN. - October 16, 2025 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients sufferin...</description>
</item>
<item>
<title>NeuroOne(R) Bolsters Patent Portfolio With Recent Decisions From Both the U.S. Patent & Trademark Office and European Patent Office</title>
<link>https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-r-bolsters-patent-portfolio-123000725</link>
<guid isPermaLink="true">https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-r-bolsters-patent-portfolio-123000725</guid>
<pubDate>Tue, 14 Oct 2025 12:30:00 GMT</pubDate>
<description>Growing IP Portfolio Signals Further Opportunity for Expansion of Company's Technology Platform EDEN PRAIRIE, MINN. - October 14, 2025 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical ...</description>
</item>
<item>
<title>NeuroOne Announces Preliminary Unaudited Product Revenue Growth of 163% to Record $9.1 Million, Invitation to Join Virtual Investor Webinar Tomorrow at 8:30 am EST</title>
<link>https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-announces-preliminary-unaudited-product-201049091</link>
<guid isPermaLink="true">https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-announces-preliminary-unaudited-product-201049091</guid>
<pubDate>Mon, 06 Oct 2025 20:10:49 GMT</pubDate>
<description>EDEN PRAIRIE, MINN. - October 6, 2025 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering...</description>
</item>
<item>
<title>NeuroOne(R) Announces Virtual Investor Webinar on October 7, 2025 at 8:30 a.m. EST</title>
<link>https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-r-announces-virtual-investor-200000552</link>
<guid isPermaLink="true">https://6ix.com/company/neuroone-medical-technologies-corp/news/neuroone-r-announces-virtual-investor-200000552</guid>
<pubDate>Mon, 29 Sep 2025 20:00:00 GMT</pubDate>
<description>EDEN PRAIRIE, MINN. - September 29, 2025 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffe...</description>
</item>
</channel>
</rss>